Encompass Health Co. (NYSE:EHC – Get Rating) – Equities researchers at Zacks Research raised their FY2023 earnings per share estimates for shares of Encompass Health in a research report issued on Thursday, June 15th. Zacks Research analyst D. Chatterjee now forecasts that the company will post earnings of $3.14 per share for the year, up from their prior estimate of $3.12. The consensus estimate for Encompass Health’s current full-year earnings is $3.19 per share. Zacks Research also issued estimates for Encompass Health’s Q1 2024 earnings at $0.80 EPS, Q3 2024 earnings at $0.81 EPS, Q4 2024 earnings at $0.93 EPS and FY2025 earnings at $3.96 EPS.
Several other analysts have also weighed in on EHC. Mizuho increased their price target on Encompass Health from $69.00 to $74.00 in a report on Monday, May 1st. Deutsche Bank Aktiengesellschaft increased their target price on Encompass Health from $70.00 to $73.00 in a research note on Monday, May 1st. Bank of America increased their target price on Encompass Health from $69.00 to $74.00 in a research note on Friday, April 28th. StockNews.com assumed coverage on Encompass Health in a research note on Thursday, May 18th. They issued a “buy” rating on the stock. Finally, Barclays increased their price target on Encompass Health from $57.00 to $61.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 4th. One analyst has rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Encompass Health has an average rating of “Buy” and a consensus target price of $70.91.
Encompass Health Stock Up 0.4 %
Encompass Health (NYSE:EHC – Get Rating) last posted its quarterly earnings results on Friday, April 28th. The company reported $0.88 earnings per share for the quarter, topping the consensus estimate of $0.70 by $0.18. Encompass Health had a return on equity of 16.80% and a net margin of 5.75%. The business had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.14 billion. During the same period in the prior year, the company posted $0.97 EPS. The firm’s revenue for the quarter was down 13.0% compared to the same quarter last year.
Institutional Trading of Encompass Health
Institutional investors have recently bought and sold shares of the business. Belpointe Asset Management LLC acquired a new stake in Encompass Health in the fourth quarter valued at approximately $25,000. Quadrant Capital Group LLC lifted its stake in shares of Encompass Health by 358.5% in the 4th quarter. Quadrant Capital Group LLC now owns 431 shares of the company’s stock valued at $26,000 after purchasing an additional 337 shares during the last quarter. U.S. Capital Wealth Advisors LLC acquired a new position in shares of Encompass Health in the 4th quarter valued at $30,000. Benjamin Edwards Inc. lifted its stake in shares of Encompass Health by 142.6% in the 1st quarter. Benjamin Edwards Inc. now owns 575 shares of the company’s stock valued at $31,000 after purchasing an additional 338 shares during the last quarter. Finally, Worth Asset Management LLC acquired a new position in shares of Encompass Health in the 1st quarter valued at $35,000. 96.14% of the stock is owned by institutional investors and hedge funds.
Encompass Health Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 17th. Shareholders of record on Monday, July 3rd will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.92%. The ex-dividend date is Friday, June 30th. Encompass Health’s payout ratio is currently 22.22%.
About Encompass Health
Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.
Featured Articles
- Get a free copy of the StockNews.com research report on Encompass Health (EHC)
- Micron Building Goodwill In Asia, Near $2 Billion Investment
- Is Twilio On The Verge Of A Comeback?
- Broadcom: All-Time Highs But Still Good Value
- Leverage AI And Build A Fortress Portfolio With Adobe
- 2 Small-Caps With Large-Cap Potential
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
